Atlas Trials

Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers

Clinical trial NCT02168595 · COMPLETED

Trial details

NCT number
NCT02168595
Sponsor
GlycoMimetics Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Adult Subjects
Start date
2014-06-01
Primary completion
2014-08-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.